Whole Slide Imaging Market Report 2026

The whole slide imaging market size has grown rapidly in recent years. It will grow from $0.88 billion in 2025 to $0.98 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing cancer diagnosis volumes, growing use of histopathology in clinical decision-making, rising adoption of digital imaging systems, expansion of pathology research activities, increasing availability of high-speed data storage.

The whole slide imaging market size is expected to see rapid growth in the next few years. It will grow to $1.48 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted diagnostics, rising demand for telepathology services, expansion of cloud-based pathology platforms, growing investments in digital healthcare infrastructure, increasing focus on diagnostic accuracy and efficiency. Major trends in the forecast period include increasing adoption of digital pathology workflows, rising integration of AI-based image analysis tools, growing demand for remote diagnostic capabilities, expansion of high-resolution slide scanning systems, enhanced focus on workflow automation.

The rising prevalence of cancer is expected to drive the growth of the whole slide imaging (WSI) market in the coming years. Cancer is a diverse group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade and destroy healthy tissue, potentially causing severe health complications or death if untreated. Factors contributing to the increasing prevalence of cancer include the obesity epidemic, inherited genetic mutations, hepatitis B and C infections, and human papillomavirus (HPV). Whole slide imaging plays a critical role in cancer diagnosis and treatment by providing detailed, accessible digital representations of tissue samples, improving the accuracy, efficiency, and collaboration in diagnosis and care, ultimately supporting better patient outcomes. For example, in May 2024, according to the American Society of Clinical Oncology, a US-based professional organization, approximately 20 million new cancer cases were recorded in 2022, and this number is projected to reach 35 million globally by 2050. Therefore, the increasing prevalence of cancer is fueling growth in the whole slide imaging market.

Key companies in the whole slide imaging market are developing innovative solutions, such as artificial intelligence (AI)-powered digital pathology platforms, to address the growing demand for remote diagnostics. AI-powered digital pathology platforms use machine-learning algorithms to analyze high-resolution whole-slide images, assisting pathologists in detecting patterns, quantifying tissue features, and prioritizing cases with greater speed and accuracy. These platforms also automate routine tasks, reduce human error, accelerate diagnostic workflows, support remote collaboration, and enhance overall diagnostic confidence. For instance, in May 2024, Indica Labs, a US-based software company, received FDA clearance for HALO AP Dx, its digital pathology platform for primary diagnosis using images captured with the Hamamatsu NanoZoomer S360MD slide scanner. HALO AP Dx is a browser-based, software-only system that enables pathologists to ingest, store, and view whole-slide images from formalin-fixed, paraffin-embedded (FFPE) tissue efficiently and precisely. The platform provides immediate remote slide access after scanning, seamless integration with laboratory information systems (LIS/LIMS), compatibility with multiple file formats, and scalable deployment options in the cloud or on-premises. Its compliance with HIPAA and FDA 21 CFR Part 11 ensures secure, regulated data management while optimizing laboratory workflow distribution.

In March 2025, Pramana Inc., a US-based AI health-tech company, partnered with ARUP Laboratories to digitize pathology slides and develop AI-powered algorithms for hematopathology diagnosis and bone marrow biopsy assessment. Through this collaboration, Pramana and ARUP aim to integrate Pramana’s SpectralHT whole-slide imaging scanners with ARUP’s hematopathology expertise to enhance diagnostic accuracy, improve workflow efficiency, and enable real-time AI-powered diagnostics using edge computing. ARUP Laboratories is a US-based nonprofit clinical and academic reference laboratory providing a wide range of diagnostic services.

Major companies operating in the whole slide imaging market are General Electric Company, F. Hoffmann-La Roche AG, Koninklijke Philips N.V., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Beckman Coulter Inc., Leica Biosystems GmbH, Hamamatsu Photonics KK, Huron Technologies International, Sectra AB, PathAI, Xifin Inc., OptraSCAN, Paige.AI, Indica Labs, 3DHISTECH Ltd., Visiopharm A/S, Flagship Biosciences Inc., Proscia Inc., LigoLab Information System, Aiforia Technologies plc, Inspirata Inc., Histowiz, Mikroscan Technologies Inc., Corista LLC, Glencoe Software Inc., Definiens AG.

North America was the largest region in the whole slide imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole slide imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the whole slide imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the whole slide imaging market by increasing costs of imported optical components, high-resolution scanners, precision sensors, computing hardware, and data storage systems used in digital pathology solutions. Healthcare providers and research institutions in North America and Europe are most affected due to dependence on imported imaging equipment, while Asia-Pacific faces cost pressures in scanner manufacturing and exports. These tariffs are increasing system acquisition costs and slowing large-scale digital pathology rollouts. However, they are also encouraging local manufacturing of imaging hardware, regional software development, and increased adoption of cost-optimized and modular whole slide imaging platforms.

The whole slide imaging market research report is one of a series of new reports that provides whole slide imaging market statistics, including whole slide imaging industry global market size, regional shares, competitors with a whole slide imaging market share, detailed whole slide imaging market segments, market trends and opportunities, and any further data you may need to thrive in the whole slide imaging industry. This whole slide imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Whole slide imaging (WSI) is a technology that scans traditional glass slides containing high-resolution tissue samples to generate digital images. This process enables pathologists to perform diagnostic work on a computer instead of a microscope, offering improved efficiency, easier case sharing and collaboration, and enhanced image analysis capabilities through digital tools.

The primary types of whole slide imaging are hardware, software, and services. Hardware works in conjunction with software, which includes the programs and operating systems that allow the computer to perform various functions. Applications of WSI include telepathology, cytopathology, immunohistochemistry, and hematopathology, and it is used by end users such as academic institutes, research centers, and other organizations.

The whole slide imaging market consist of revenues earned by entities by providing services such as slide scanning services, digital archiving and storage, image analysis and quantification, and custom application development. The market value includes the value of related goods sold by the service provider or included within the service offering. The whole slide imaging market also includes sales of image analysis tools, integrated digital pathology systems, WSI viewing platforms, telepathology systems, and WSI scanners. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.